News Releases

SenesTech Announces Joint Project with Island Conservation

FLAGSTAFF, Ariz., Jan. 8, 2020 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that it was launching a deployment project with Island Conservation. The project will specifically look at developing further protocols for deploying ContraPest® in environmentally sensitive areas, such as corporate campuses and conservation areas. Island Conservation and its corporate partners will purchase the ContraPest from SenesTech on standard terms, and SenesTech will contribute planning and deployment support.

SenesTech, Inc. has developed an innovative technology for managing animal pest populations through fertility control as opposed to a lethal approach. The Company's first fertility control product, ContraPest(R), is marketed for use initially in controlling rat infestations. (PRNewsfoto/SenesTech, Inc.) (PRNewsfoto/SenesTech, Inc.)

"This project will potentially open up two distinct verticals for us, sustainably managed corporate campuses and environmentally sensitive conservation areas, partnered with a leading authority on sustainable environmental practices," said Kenneth Siegel, SenesTech's CEO.  "As with our other deployment projects, we specifically target the highest impact opportunities."

"Because invasive rodent eradications on islands has become a mainstream intervention to prevent species extinctions and protect island communities, the island restoration community is in need of a diversified toolbox to take on bigger and more complex island eradications.  This project will allow us to evaluate deployment strategies for Contrapest in island biosecurity settings (prevention and detection), and in control settings to protect threatened species," said Gregg Howald, Island Conservation's Director of Global and External Affairs.  "The goal of this project is to determine how best to use ContraPest at scale to sustainably control a rodent population. We will start deployment in the corporate campus type of environment at approximately two stations per acre, then optimize deployment to maintain populations as the project progresses. We look forward to demonstrating that ContraPest will have all the benefits of controlling rats while eliminating the risks from traditional pesticide-based tools."

About SenesTech 

SenesTech is changing the paradigm of pest management by targeting one of the root causes of the problem: reproduction.

ContraPest® is an innovative technology with an approach that targets the reproductive capabilities of both sexes in rat populations, inducing egg loss in female rats and impairing sperm development in males. Using a proprietary bait delivery method, ContraPest® is dispensed in a highly palatable liquid formulation that promotes sustained consumption by rat communities. ContraPest® is designed, formulated and dispensed to be low hazard for handlers and non-target species such as wildlife, livestock and pets, where the active ingredients break down rapidly.

We believe ContraPest® will establish a new paradigm in rodent control, resulting in a decreased reliance on lethal options. For more information visit the SenesTech website at

Safe Harbor Statement
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors and other risks identified in our filings with the Securities and Exchange Commission. Forward looking statements include, but are not limited to, our expectation regarding sales commitments, our expectation regarding the conversion of sales commitments and programs to revenue, our belief that our product is more humane, less harmful to the environment and more effective than traditional methods, and our belief that ContraPest will establish a new paradigm in rodent control without environmental effects of rodenticides.  All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.


Investor: Robert Blum, Joe Dorame, Joe Diaz, Lytham Partners, LLC, 602-889-9700,

Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., 928-779-4143

SOURCE SenesTech, Inc.